These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3244183)

  • 21. An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole.
    Higuchi K; Tanabe S; Koizumi W; Nakayama N; Sasaki T; Nagaba S; Saigenji K; Katada N
    Hepatogastroenterology; 2004; 51(57):774-6. PubMed ID: 15143914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
    Ekström P; Carling L; Unge P; Anker-Hansen O; Sjöstedt S; Sellström H
    Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.
    Saitoh T; Fukushima Y; Otsuka H; Hirakawa J; Mori H; Asano T; Ishikawa T; Katsube T; Ogawa K; Ohkawa S
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1811-7. PubMed ID: 12269976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
    Bell NJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting quality of ulcer healing after lansoprazole treatment.
    Ito G; Nakagawara M; Watanabe F; Ooi S; Nawano M; Hanai H; Kaneko E
    J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
    Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
    Brummer RJ; Stockbrügger RW
    Dig Dis Sci; 1996 Oct; 41(10):2048-54. PubMed ID: 8888720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA; Samsom M; Smout AJ
    Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
    [No Abstract]   [Full Text] [Related]  

  • 29. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients.
    Tsai WL; Poon SK; Yu HK; Chang CS; Yeh HZ; Ko CW; Chen GH
    Aliment Pharmacol Ther; 2000 Jan; 14(1):123-7. PubMed ID: 10632655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
    Geus WP; Mulder PG; Nicolai JJ; Van den Boomgaard DM; Lamers CB
    Aliment Pharmacol Ther; 1998 Apr; 12(4):329-35. PubMed ID: 9690721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
    J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin.
    Jaup BK
    Helicobacter; 1996 Dec; 1(4):260-1. PubMed ID: 9398878
    [No Abstract]   [Full Text] [Related]  

  • 34. Lansoprazole in the prophylaxis of acid aspiration during elective surgery.
    Hett DA; Scott RC; Risdall JE
    Br J Anaesth; 1995 May; 74(5):614-5. PubMed ID: 7772441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules.
    Sharma VK; Ugheoke EA; Vasudeva R; Howden CW
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1171-4. PubMed ID: 9845407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
    Kim JI; Park SH; Kim JK; Chung IS; Chung KW; Sun HS
    Helicobacter; 2002 Dec; 7(6):331-6. PubMed ID: 12485118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of every-other day administration of proton pump inhibitors from the standpoint of continuous 48-hour pH measurements-- Comparison of cimetidine, omeprazole, and lansoprazole].
    Yamamoto Y; Sezai S; Sakurabayashi S; Hirano M; Oka H
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jun; 92(6):919-24. PubMed ID: 7609313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
    Paul G; Ramdani A; Mignon M; Vallot T; Forestier S; Cadiot G; Ruszniewski P; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(8-9):695-701. PubMed ID: 7875436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.